Enlightify (ENFY) faces NYSE minimum price deficiency with cure deadline in 2026

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Enlightify Inc. received a notice from the New York Stock Exchange on August 27, 2025 that its 30‑trading‑day average closing price had fallen below $1.00 per share, which is the NYSE’s minimum price required to keep its common stock listed under Rule 802.01C.

The company has 10 business days from receipt of the notice to inform the NYSE of its plan to cure this share price deficiency. To regain compliance, both the ending and 30‑trading‑day average closing price of the common stock must be at or above $1.00 on February 27, 2026, or on the last trading day of any earlier month. Enlightify plans to notify the NYSE of its intent to cure by September 11, 2025 and has already issued a press release on September 2, 2025 describing the non‑compliance notice.

Positive

None.

Negative

NYSE minimum price non‑compliance and delisting risk: Enlightify Inc. has fallen below the NYSE’s $1.00 30‑day average price requirement, and must restore both its ending and 30‑day average share price to at least $1.00 by February 27, 2026 or risk delisting.

Insights

NYSE price non‑compliance raises delisting risk if Enlightify cannot lift its share price.

The notice confirms that Enlightify Inc. fell below the NYSE’s $1.00 minimum average closing price requirement over 30 trading days. This triggers a formal cure period under NYSE Rule 802.01C but does not immediately remove the stock from the exchange.

The company must show both an ending and 30‑day average share price at or above $1.00 by February 27, 2026, or by the last trading day of any earlier month, to regain compliance. If it fails, the NYSE could begin delisting procedures, which often push trading to over‑the‑counter markets with typically lower liquidity.

The company states it will notify the NYSE of its intent to cure by September 11, 2025 and has already issued a press release on September 2, 2025. Future disclosures in company filings may specify which measures it pursues to address the share price deficiency.

8-K Event Classification

2 items: 3.01, 9.01

2 items

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice or transferred its listing to a different exchange.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

09/02/2025 - 05:10 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 27, 2025

Enlightify Inc.

(Exact name of Registrant as specified in charter)

Nevada	001-34260	36-3526027
(State or other jurisdiction	(Commission File No.)	(IRS Employer
of Incorporation)		Identification No.)

3^rd Floor, Borough A, Block A.

No.181 South Taibai Road

Xi’an, Shaanxi Province

People’s Republic of China 710065

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: +86-29-88266368

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)

☐

Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		ENFY		NYSE

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On August 27, 2025, the New York Stock Exchange (“NYSE”) notified Enlightify Inc. (the “Company”) that the 30-trading-day average closing price of the Company’s common stock had fallen below $1.00 per share, the minimum average share price required for continued listing of the Company’s common stock on the NYSE under Rule 802.01C of the NYSE Listed Company Manual.

Under NYSE rules, the Company has 10 business days from its receipt of the notification to inform the NYSE of its intent to cure the share price deficiency to return to compliance with this continued listing standard.

In order to return to compliance with this continued listing standard, the ending and 30-trading-day average share price of the Company’s common stock must equal or exceed $1.00 on February 27, 2026 (six months from the Company’s receipt of the notification, unless extended) or on the last trading day of any month prior to that date. No later than September 11, 2025, the Company will notify the NYSE of its intent to cure the share price deficiency and regain compliance with this continued listing standard.

On September 2, 2025, as required by NYSE rules, the Company issued a press release announcing that it had received the notification of non-compliance. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Press Release dated September 2, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 2, 2025	ENLIGHTIFY INC.
	(Registrant)

	By:	/s/ Zhuoyu Li
		Zhuoyu Li
		Chairman of the Board of Directors, Chief Executive Officer, and President

Source: View Original Filing on SEC EDGAR

FAQ

What NYSE notice did Enlightify Inc. (ENFY) receive in August 2025?

Enlightify Inc. received a New York Stock Exchange notice on August 27, 2025 that its 30‑day average closing price fell below $1.00 per share, breaching the NYSE’s minimum price requirement for continued listing under Rule 802.01C of the NYSE Listed Company Manual.

What must Enlightify Inc. (ENFY) do to regain NYSE listing compliance?

To regain compliance, Enlightify’s common stock must have both an ending and 30‑trading‑day average closing price at or above $1.00 on February 27, 2026 or on the last trading day of any earlier month during the NYSE‑defined cure period.

How long does Enlightify Inc. (ENFY) have to respond to the NYSE notice?

Enlightify has 10 business days from receiving the NYSE notice on August 27, 2025 to inform the exchange of its intent to cure the share price deficiency and pursue steps to return to compliance with the NYSE’s continued listing standard.

What key dates are associated with Enlightify Inc.’s (ENFY) NYSE deficiency notice?

Key dates include August 27, 2025, when the NYSE notified Enlightify; September 11, 2025, by which it will notify the NYSE of its cure plan; and February 27, 2026, the six‑month deadline to restore both ending and 30‑day average price to at least $1.00.

Did Enlightify Inc. (ENFY) publicly disclose the NYSE non‑compliance notice?

Yes. Enlightify issued a press release on September 2, 2025 announcing it had received the NYSE notification of non‑compliance with the $1.00 minimum share price requirement. The press release is filed as Exhibit 99.1 to the company’s current report.